Standardized pipeline for establishing, expanding, and differentiating airway and alveolar organoids from human BAL fluid
Taryn B. Gellner, Belinda Chen, Shreyas R. Raini, Mackenzie S. Jackson, Amy K. Kraak, Sophie C. Petta, Margherita PaschiniiD, Lynn M. SchnappiD, Carla F. KimiD, Monica Yun LiuiD
Abstract
Lung organoids are versatile experimental models, but their broader use in studying human disease is limited by the scarcity of starting material and the complexity of current methods. To align organoid technology with common clinical practice, we developed airway and alveolar organoids using cells obtained from patients bronchoalveolar lavage (BAL) fluid. Building on existing techniques, we showed that BAL is a reliable, accessible source of primary human epithelial cells, yielding airway and alveolar organoids within 10 days. Organoids can then be expanded over many passages for downstream analysis. Our streamlined methods do not require cell sorting or other complex procedures, all cells are derived from a single patient, and media are based on serum-free, chemically-defined formulations. Here, we present detailed protocols for organoid establishment, standardized passaging and phenotyping, and differentiation of both airway and alveolar models. We provide a time course of BAL-derived airway organoid differentiation at air-liquid interface, and we demonstrate proof of principle for differentiation of BAL-derived alveolar organoids in 3D culture. These methods can be readily adapted to generate and characterize organoids from lung tissue, tracheobronchial specimens, or other primary cells from humans or mice, expanding the potential to use lung organoids for disease modeling. NEW AND NOTEWORTHYWe provide streamlined protocols to generate both airway and alveolar epithelial organoids from a single, clinical BAL specimen. From standardized specimen collection to organoid plating to passaging and differentiation, we show that rare, primary epithelial cells in BAL can give rise to all the major airway and alveolar cell types. Our serum-free, feeder-free, sorting-free methods offer a simplified starting point for using patient-derived organoids to model lung disease. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=97 SRC="FIGDIR/small/682184v1_ufig1.gif" ALT="Figure 1"> View larger version (24K): org.highwire.dtl.DTLVardef@e0abe2org.highwire.dtl.DTLVardef@349f9aorg.highwire.dtl.DTLVardef@da4b0eorg.highwire.dtl.DTLVardef@175a97f_HPS_FORMAT_FIGEXP M_FIG Graphical Abstract Standardized pipeline for BAL organoids. Created in BioRender. C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- FWCI
- 4.75
- Field percentile
- top 8%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Patient-derived airway organoids from BAL fluid model injury and therapy responses in neonatal bronchopulmonary dysplasia
Shilpa Sonti, Abiud Cantu, … Krithika Lingappan·bioRxiv·Aug 11, 2025
- Long-term expanding human airway organoids for disease modelling.
N. Sachs, D. D. Zomer-van Ommen, … H. Clevers·bioRxiv·May 9, 2018
- Protocol for primary human lung organoid-derived air-liquid interface in vitro model to study response to SARS-CoV-2
D. C. Castaneda, S. Jangra, … K. Palucka·bioRxiv·Sep 10, 2023
- Development of novel in vitro human alveolar epithelial cell models to study distal lung biology and disease
E. Tran, T. Shi, … I. A. Offringa·bioRxiv·Dec 25, 2020
- Microstructured hydrogels to guide self-assembly and function of lung alveolospheres
C. Loebel, A. Weiner, … J. Burdick·bioRxiv·Aug 30, 2021
- Development of a Novel Air-Liquid Interface Airway Tissue Equivalent Model for In Vitro Respiratory Modeling Studies
T. Leach, U. Gandhi, … S. V. Murphy·bioRxiv·Sep 21, 2022